$70,000 of DAVITA INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of dialysis patients covered by government and private insurance. H.R. 2199 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with End Stage Renal Disease. H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of dialysis patients covered by government and private insurance. H.R. 2199 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with End Stage Renal Disease."
You can find more data on corporate lobbying on Quiver Quantitative.
DVA Insider Trading Activity
DVA insiders have traded $DVA stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:
- HATHAWAY INC BERKSHIRE has made 0 purchases and 19 sales selling 953,091 shares for an estimated $147,740,046.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DVA Hedge Fund Activity
We have seen 218 institutional investors add shares of DVA stock to their portfolio, and 315 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 607,396 shares (+409.9%) to their portfolio in Q4 2024, for an estimated $90,836,071
- BLACKROCK, INC. removed 465,288 shares (-9.9%) from their portfolio in Q4 2024, for an estimated $69,583,820
- BANK OF AMERICA CORP /DE/ removed 431,630 shares (-69.0%) from their portfolio in Q4 2024, for an estimated $64,550,266
- EPOCH INVESTMENT PARTNERS, INC. added 368,436 shares (+inf%) to their portfolio in Q4 2024, for an estimated $55,099,603
- JPMORGAN CHASE & CO removed 332,508 shares (-59.2%) from their portfolio in Q4 2024, for an estimated $49,726,571
- CITADEL ADVISORS LLC removed 332,336 shares (-76.6%) from their portfolio in Q4 2024, for an estimated $49,700,848
- HOLOCENE ADVISORS, LP added 302,154 shares (+inf%) to their portfolio in Q4 2024, for an estimated $45,187,130
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
